Progression Risk Score Estimation Based on Immunostaining Data in Oral Cancer Using Unsupervised Hierarchical Clustering Analysis: A Retrospective Study in Taiwan

This study aimed to investigate whether the progression risk score (PRS) developed from cytoplasmic immunohistochemistry (IHC) biomarkers is available and applicable for assessing risk and prognosis in oral cancer patients. Participants in this retrospective case-control study were diagnosed between...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hui-Ching, Chan, Leong-Perng, Wu, Chun-Chieh, Hsiao, Hui-Hua, Liu, Yi-Chang, Cho, Shih-Feng, Du, Jeng-Shiun, Liu, Ta-Chih, Yang, Cheng-Hong, Pan, Mei-Ren, Moi, Sin-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466609/
https://www.ncbi.nlm.nih.gov/pubmed/34575686
http://dx.doi.org/10.3390/jpm11090908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466609/
https://www.ncbi.nlm.nih.gov/pubmed/34575686
http://dx.doi.org/10.3390/jpm11090908

Ejemplares similares